The budget's $234 million boost to support business research and development is a “clever” investment that is bound to ripen hefty returns.
Brad Duft, president of CoDa Therapeutics, a company operating locally and in the US, told the Natio
Kristina Koveshnikova Wed, 11 Jul 2018
The budget’s $234 million boost to support business research and development is a “clever” investment that is bound to ripen hefty returns.
Brad Duft, president of CoDa Therapeutics, a company operating locally and in the US, told the National Business Review that New Zealand has tremendous
Want to read more? It's easy.
Choose your best value subscription option
Get instant access to this article now as part of our FREE two week trial.
Get two weeks free access to NBR’s Premium Online Subscription, which includes full access to all of NBR’s great content on any device.